Synthetic biology “Design” alone is not enough to develop commercially viable strains
We go beyond the “Design” of microorganisms through synthetic biology, refining strain improvement technologies to develop microorganisms for commercial-scale production.
How Can We Develop Strains for Real-World Production?
Synthetic biology “Design” is limited in scope and cannot precisely engineer the complex regulatory mechanisms of the entire strain. To cultivate a strain and produce a target product, it is necessary to address not only the metabolic pathways responsible for production, but also the complex regulation of gene expression and metabolic pathways arising from dynamic interactions between the cultivation environment and the intracellular state.
CHITOSE’s Track Record in Developing Strains
for Commercial-Scale Production
Expertise in Microorganisms for
Continuously Refining Our Strain Development Technologies
20
+ Years
100
Track Record in Strain Development
Track Record of Industry Collaboration
Across a wide range of strains and functional improvements
+ Projects
50
Across a wide range of industries, including food, pharmaceuticals, algae, agriculture, and environmental applications
Track Record of Industry Collaboration
+ companies
Enhancing Production Yields, Optimizing Strain Characteristics, and More.
Beyond increasing production yields, we can modify cell viscosity and other strain characteristics to enhance production performance. Our strength lies in integrating genetic design, strain improvement, and cultivation process development.
SERVICE FLOW
Service Flow From consultation to delivery
We work closely with you throughout the process to develop strains that better meet your specific requirements.
If desired, we also offer consultation on optimizing strain cultivation methods and conditions.
＊Although our proprietary technologies have been shown to work across a wide range of organisms, we first evaluate its mutagenic effects for each new target before initiating strain improvement.